LLY

966.05

+1.94%↑

JNJ

221.47

+0.16%↑

ABBV

202.89

+0.87%↑

UNH

384.38

+1.3%↑

AZN

181.75

-0.31%↓

LLY

966.05

+1.94%↑

JNJ

221.47

+0.16%↑

ABBV

202.89

+0.87%↑

UNH

384.38

+1.3%↑

AZN

181.75

-0.31%↓

LLY

966.05

+1.94%↑

JNJ

221.47

+0.16%↑

ABBV

202.89

+0.87%↑

UNH

384.38

+1.3%↑

AZN

181.75

-0.31%↓

LLY

966.05

+1.94%↑

JNJ

221.47

+0.16%↑

ABBV

202.89

+0.87%↑

UNH

384.38

+1.3%↑

AZN

181.75

-0.31%↓

LLY

966.05

+1.94%↑

JNJ

221.47

+0.16%↑

ABBV

202.89

+0.87%↑

UNH

384.38

+1.3%↑

AZN

181.75

-0.31%↓

Search

Elanco Animal Health Inc

Open

SectorGezondheidszorg

21.88 -7.45

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

21.86

Max

23.65

Belangrijke statistieken

By Trading Economics

Inkomsten

-198M

-232M

Verkoop

7M

1.1B

K/W

Sectorgemiddelde

372.714

49.8

Winstmarge

-20.28

Werknemers

9,400

EBITDA

-172M

6M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+23.76% upside

Dividenden

By Dow Jones

Volgende Winsten

6 aug 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-1.1B

11B

Vorige openingsprijs

29.33

Vorige sluitingsprijs

21.88

Nieuwssentiment

By Acuity

50%

50%

153 / 347 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Elanco Animal Health Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

10 mei 2026, 23:47 UTC

Marktinformatie

Gold Falls on Renewed Inflation Concerns -- Market Talk

10 mei 2026, 23:44 UTC

Marktinformatie

Nikkei May Rise on Signs of U.S. Economic Strength -- Market Talk

10 mei 2026, 23:38 UTC

Marktinformatie

Oil Rises Amid Signs of Ongoing Middle East Tensions -- Market Talk

10 mei 2026, 23:14 UTC

Marktinformatie

Australia's Political Map Continues to Be Redrawn -- Market Talk

10 mei 2026, 22:22 UTC

Acquisities, Fusies, Overnames

Elevra Lithium: Expects Deal to Close in 1Q FY27

10 mei 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Elevra Lithium: Expects to Received About $71 Million Before Fees, Taxes in Cash

10 mei 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Elevra Lithium Agrees to Sell Ewoyaa Lithium Project Stake to Zhejiang Huayou Cobalt

10 mei 2026, 10:21 UTC

Winsten

Saudi Aramco Profit Jumps Despite War Disrupting Shipping Routes -- WSJ

9 mei 2026, 06:05 UTC

Winsten

Our Innodata Stock Pick Smashed Earnings Expectations. Stay Long. -- Barrons.com

8 mei 2026, 23:55 UTC

Winsten

Review & Preview: Still Going Strong -- Barrons.com

8 mei 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

8 mei 2026, 20:49 UTC

Winsten

Why the Gap Between Chip and Software Stocks Keeps Getting Wider -- Barrons.com

8 mei 2026, 20:25 UTC

Winsten

These Stocks Are Today's Movers: Rocket Lab, Moderna, HubSpot, Nvidia, CoreWeave, Trade Desk, Cloudflare, Fluor, Akamai, IREN, and More -- Barrons.com

8 mei 2026, 19:43 UTC

Winsten

Cencosud 1Q Rev $4.565B >CENCOSUD.SN

8 mei 2026, 19:43 UTC

Winsten

Cencosud 1Q Net $115M

8 mei 2026, 19:20 UTC

Marktinformatie

Oil Futures End Session Higher, But Down on the Week -- Market Talk

8 mei 2026, 19:18 UTC

Winsten

Monster and Celsius Earnings Show Energy-Drink Fatigue Is Far From Over -- Barrons.com

8 mei 2026, 19:16 UTC

Winsten

This Mini Berkshire Hathaway Is a Buy. An Activist Investor Is Pushing to Break It Up. -- Barrons.com

8 mei 2026, 19:08 UTC

Winsten

This Mini Berkshire Hathaway Is a Buy. An Activist Investor Is Pushing to Break It Up. -- Barrons.com

8 mei 2026, 19:05 UTC

Winsten

Investors Feared Energy-Drink Fatigue. Monster and Celsius Earnings Offered Reassurance. -- Barrons.com

8 mei 2026, 19:02 UTC

Marktinformatie

U.S. Natural Gas Futures Little Changed on Week -- Market Talk

8 mei 2026, 18:51 UTC

Winsten

Memory Stocks Continue to Surge. What's Driving Micron and Sandisk Higher. -- Barrons.com

8 mei 2026, 18:49 UTC

Winsten

These Stocks Are Today's Movers: Rocket Lab, Moderna, HubSpot, Nvidia, CoreWeave, Trade Desk, Cloudflare, Fluor, Akamai, IREN, and More -- Barrons.com

8 mei 2026, 18:41 UTC

Winsten

McDonald's Stock Rises on Earnings Beat. The Value Push Needs to Maintain Momentum. -- Barrons.com

8 mei 2026, 17:38 UTC

Marktinformatie

U.S. Oil Rig Count Rises By 2 to 410 -- Market Talk

8 mei 2026, 17:14 UTC

Winsten

How High Gas Prices Need to Rise to Boost Electric Vehicle Sales -- Barrons.com

8 mei 2026, 17:04 UTC

Marktinformatie

Zcash Caps Off Parabolic Week -- Market Talk

8 mei 2026, 16:20 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

8 mei 2026, 16:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

8 mei 2026, 16:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Elanco Animal Health Inc Prognose

Koersdoel

By TipRanks

23.76% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 29.27 USD  23.76%

Hoogste 32 USD

Laagste 24 USD

Gebaseerd op 12 Wall Street-analisten die 12-maands prijsdoelen bieden voor Elanco Animal Health Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

12 ratings

11

Buy

1

Hold

0

Sell

Technische score

By Trading Central

9.77 / N/ASteun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Strong Bullish Evidence

Lange Termijn

Weak Bullish Evidence

Sentiment

By Acuity

153 / 347 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
help-icon Live chat